Skip to main content

Beneficial ownership — 13D / 13G

87,339 recent Schedule 13D / 13G filings — activist (13D) and passive (13G) stakes above 5% of a class.

Reporting person Issuer Schedule % of class Filed
Rubric Capital Management LP XPER Xperi Inc. 13D/A 9% 2y
George Economou SHIP Seanergy Maritime Holdings Corp. 13D/A 8.9% 2y
Ned L. Sherwood BRN Barnwell Industries Inc 13D/A 29.98% 2y
SHIPYARD CAPITAL MANAGEMENT LLC ROYT PACIFIC COAST OIL TRUST 13D/A 8.57% 2y
GAMCO INVESTORS, INC. ET AL BATRA Atlanta Braves Holdings, Inc. 13D/A 21.42% 2y
Sanofi INBX Inhibrx Biosciences, Inc. 13G 8% 2y
Alibaba Group Holding Ltd BZUN Baozun Inc. 13G/A 0% 2y
GAMCO INVESTORS, INC. ET AL TG Tredegar Corp 13D/A 13.89% 2y
Braden Ferrari BTLN Brightline Interactive, Inc. 13G/A 5.2% 2y
William S. Fisher GAP Gap Inc 13D/A 16.8% 2y
James N. Topper HLVX HilleVax, Inc. Common Stock 13D/A 21.4% 2y
Privet Fund LP ACNT Ascent Industries Co. 13D/A 16.5% 2y
Starboard Value LP GDOT Green Dot Corp 13D/A 9.4% 2y
Karpus Management, Inc. NEA Nuveen AMT-Free Quality Municipal Income Fund 13D/A 8.44% 2y
Anthony Tamer WHF WhiteHorse Finance, Inc. 13D/A 19.09% 2y
Parag Saxena RVPH Reviva Pharmaceuticals Holdings, Inc. 13D/A 18.5% 2y
GIP II Blue Holding, L.P. HESM Hess Midstream LP 13D/A 36.2% 2y
Heng Fai Ambrose Chan AEI Alset Inc. 13D/A 61.2% 2y
CMLS Holdings LLC WGS GeneDx Holdings Corp. 13D/A 14.9% 2y
Sami Mnaymneh WHF WhiteHorse Finance, Inc. 13D/A 17.11% 2y
Karpus Management, Inc. NRK Nuveen New York Amt-Free Quality Municipal Income Fund 13D/A 23.86% 2y
BOSTON OMAHA Corp SKYH Sky Harbour Group Corp 13D/A 62.3% 2y
THRC Holdings, LP ACDC ProFrac Holding Corp. 13D/A 47.6% 2y
EcoR1 Capital, LLC HOOK HOOKIPA Pharma Inc. 13G 5.9% 2y
Mitchell P. Kopin PARA Parabolic Technologies, Inc. 13G 4.99% 2y
Venrock Healthcare Capital Partners III, L.P. ERAS Erasca, Inc. 13G 6.5% 2y
DANIEL ASHER APLD Applied Digital Corp. 13G 8.79% 2y
Timothy J. Langer TSBX Turnstone Biologics Corp. Common Stock 13G/A 4.3% 2y
Rubric Capital Management LP HRTX Heron Therapeutics, Inc. 13D/A 17.7% 2y
OH Cypress Aggregator, L.P. CCC CCC Intelligent Solutions Holdings Inc. 13D/A 5.3% 2y
LB Partners LLC WOW WideOpenWest, Inc. Common Stock 13D 7.9% 2y
Deerfield Management Company, L.P. HLSQ Tessera Defense & Homeland Security Inc. 13D/A 8.75% 2y
Camac Partners, LLC TSPH TuSimple Holdings Inc. 13D/A 5.6% 2y
Irrevocable Larson Family Investment Trust SCOR Comscore, Inc. 13G/A 5.5% 2y
Champion Kerry Inc. BZUN Baozun Inc. 13D 15.6% 2y
Irrevocable Larson Family Investment Trust RMTI Rockwell Medical, Inc. 13G/A 6.3% 2y
FPR PARTNERS LLC SNPO Snap One Holdings Corp. Common Stock 13G/A 0% 2y
Shasta Ventures II GP, LLC NXDR Nextdoor Holdings, Inc. 13D/A 6% 2y
Cochlear Ltd NYXH Nyxoah SA 13D/A 16.53% 2y
Caligan Partners LP ANIK Anika Therapeutics, Inc. 13D/A 9.7% 2y
Nordson Corporation ATRI Atrion Corp 13D 22% 2y
Senvest Management, LLC AVDX AvidXchange Holdings, Inc. Common Stock 13G 5% 2y
Luis Dussan LIDR AEye, Inc. 13D/A 4.29% 2y
Tony L. Alford LCU Lion Copper Corp. 13D/A 34.5% 2y
Ramaswamy Vivek BZFD BuzzFeed, Inc. 13D/A 8.4% 2y
MILLENNIUM MANAGEMENT LLC ANGO Angiodynamics Inc 13G 5.1% 2y
Ever Orient International Limited BEKE KE Holdings Inc. 13D 5.1% 2y
Mitchell P. Kopin EDBL Edible Garden AG Inc 13G 4.99% 2y
RA CAPITAL MANAGEMENT, L.P. GPCR Structure Therapeutics Inc. 13G 5.2% 2y
BIOTECHNOLOGY VALUE FUND L P FHTX Foghorn Therapeutics Inc. 13G 9.99% 2y